VYALEV is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
Indoco is comprehensively working on the remedial action plan
Strokes are affecting approximately 1.8 million people annually
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Based on ECHO Phase III trial which demonstrated Calquence combination reduced risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy
Poor oral health (periodontal disease) impacts nearly 51% of Indians
HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
Potential of Ayurveda’s contribution in global health system through various innovative practices
Subscribe To Our Newsletter & Stay Updated
